期刊文献+

间充质干细胞在致敏受者造血干细胞移植中的作用 被引量:1

Effects of Mesenchymal Stem Cells in Hematopoietic Stem Cells Transplantation for Sensitized Recipients
下载PDF
导出
摘要 【目的】本实验拟研究骨髓间充质干细胞(MSC)在致敏受者造血干细胞移植中的作用。【方法】体外分离BALB/c小鼠骨髓细胞,通过贴壁培养方法获得MSC,应用流式细胞仪检测细胞表面分子标记。通过异基因脾细胞输注方法建立致敏动物模型;绿色荧光染料标记骨髓MSC,分别移植到非致敏及致敏受者体内,并于移植后不同时间点检测MSC的归巢情况。致敏BALB/c小鼠经照射预处理,联合应用同基因MSC与异基因骨髓细胞移植,每日观察小鼠的生存情况。【结果】体外培养第4代MSC表现为长梭形,阴性表达造血细胞表面分子而阳性表达粘附分子。动物体内实验发现移植后第48小时,MSC在非致敏受者体内主要归巢于骨髓,而在致敏受者体内主要归巢于脾脏。造血干细胞移植实验中,致敏小鼠接受同基因骨髓MSC与异基因骨髓细胞移植,结果发现致敏小鼠在移植后第12~16天全部死亡,生存中位数时间是14 d。【结论】成功培养小鼠骨髓MSC;移植后MSC在致敏受者体内主要归巢于脾脏组织;联合应用MSC移植并不能有效促进异基因造血干/祖细胞在致敏受者体内植入。 [Objective ] The study was aimed to study the effects of mesenchymal stem cells (MSC) in hematopoietic stem cell transplantation for sensitized recipients. [ Methods ] Bone marrow cells derived from BALB/c mice were cultured in vitro. The molecular markers and the function of MSC were detected by flow cytometry. A murine model of sensitization was established by transfusion of allogeneic spleen ceils. MSC labeled with green fluorescent dye were transplanted into non-sensitized and sensitized recipients, and the homing of MSC in vivo was monitored at different time points post transplantation. Additionally, sensitized BALB/ c mice under irradiation were transplanted with syngeneic MSC and allogeneic bone marrow cells, and the rate of survival was monitored daily. [ Results] The results showed that the fourth passage of MSC presented typical spindle-shape morphology. The MSC were lack of expression of hematopoietic tell markers but with expression of adherent markers. Forty-eight hours post transplantation, the homing of MSC was found mainly in bone morrow of non-sensitized recipient and spleen of sensitized recipient, respectively. The hematopoietic stem cell transplantation showed that all the sensitized recipients died at 12 to 16 days after receiving syngeneic MSC and allogeneic bone marrow cells, with a median of 14 days. [Conclusion] Successfully cultured murine MSC in vitro. The MSC mainly homed to spleen of sensitized recipient post transplantation, fusthermore, MSC could not enhance engraftment of allogeneic hematopoietic stem/progenitor cells in sensitized recipients.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2013年第2期225-229,共5页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省科技计划项目(2012B031800074)
关键词 间充质干细胞 致敏受者 造血干细胞移植 mesenchymal stem cells sensitized recipients hematopoietic stem cell transplantation
  • 相关文献

参考文献11

  • 1Xu LH, FangJP, Huang WG, et al. Marrow graft rejection by repeated transfusions of allogeneic donor spleen cells[J]. Bone Marrow Transplant, 2007, 40 (7): 691-698.
  • 2Garcia -G6mez I, Elvira G, Zapata AG, et al. Mesenchymal stem cells: biological properties and clinical applications[J]. Expert Opin BioI Ther, 2010, 10( 10) : 1453- 1468.
  • 3周敦华,黄科,吴燕峰,沈婷,黄绍良.间充质干细胞及其培养上清与融冻产物对脐血CD34^+细胞扩增及分化的作用[J].中山大学学报(医学科学版),2010,31(1):39-44. 被引量:2
  • 4TolarJ, Villeneuve P, Keating A. Mesenchymal stromal cells for graft-versus-host disease[J]. Hum Gene Ther, 2011,22(3): 257-262.
  • 5Terasaki PI, Ozawa M, Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival[J]. AmJ Transplant, 2007, 7 (2): 408-415.
  • 6Taylor PA, Ehrhardt MJ, Roforth MM, et al. Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients[J]. Blood, 2007, 109(3): 1307-1315.
  • 7Vo AA, Peng A, Toyoda M, et al. Use of intravenous immune globulin and rituximab for desensitization of highly HLA -sensitized patients awaiting kidney transplantation[J]. Transplantation, 2010, 89 (9) : 1095-1102.
  • 8Xu H, Chilton PM, Tanner MK, et al. Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients[J]. Blood, 2006, 108(10): 3611-3619.
  • 9蔡耘,黄绍良,陈凤英,黄文革,魏菁,车丽洪.同种异基因小鼠骨髓腔内脐血移植模型的建立及其对造血干细胞植入的影响[J].中山大学学报(医学科学版),2005,26(6):644-650. 被引量:8
  • 10Cai Y, Huang SL, Chen FY, et al. Establishment of a murine model for allogeneic umbilical cord blood transplantation by intra -bone marrow injection and its effects on the engraftment of HSCs[J]. Sun Yat-sen Univ , Med Sci, 2005, 26(6): 644-650.

二级参考文献23

  • 1孙爱红,冯四洲,刘斌,汤锋武,冯义,卢士红,韩忠朝.NOD/SCID小鼠脐血单个核细胞骨髓腔内移植的实验研究[J].中华血液学杂志,2005,26(5):261-264. 被引量:14
  • 2周敦华,魏菁,黄绍良,方建培,包蓉,吴燕峰,黎阳.人脐血来源MSCs的主要生物学特性的研究[J].中国病理生理杂志,2006,22(8):1606-1609. 被引量:7
  • 3马俐君,高磊,周虹,邱慧颖,胡晓霞,解琳娜,王健民.人骨髓间充质干细胞体外支持脐血CD34^+细胞增殖的研究[J].中国实验血液学杂志,2006,14(5):949-954. 被引量:7
  • 4Ball LM,Bemardo ME,Locatelli F,et al.Potential role of mesenchymal stromal cells in pediatric hematopoietic SCT[J].Bone Marrow Transplant,2008,42 (Suppl 2):S60-66.
  • 5Polchert D,Sobinsky J,Douglas G,et al.IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease[J].Eur J Immunol,2008,38(6):1479-1482.
  • 6Le Blanc K,Frassoni F,Ball L,et al.Mesenchymal stem cells for treatment of steroid-resistant,severe,acute graft-versus-host disease:a phase Ⅱ study[J].Lancet,2008,371 (9624):1553-1554.
  • 7del Caf(n)izo MC,Lopez N,Vazquez L,et al.Hematopoietic damage prior to PBSCT and its influence on hematopoietic recovery[J].Haematologica,1999,84(6):511-516.
  • 8Cui J,Wahl RL,Shen T,et al.Bone marrow cell trafficking following intravenous administration[J].Br J Haematol,1999,107(4):895-902.
  • 9Huang GP,Pan ZJ,Jia BB,et al.Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood[J].Cell Transplant,2007,16 (6):579-585.
  • 10Bakhshi T,Zabriskie RC,Bodie S,et al.Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture[J].Transfusion,2008,48(12):2638-2644.

共引文献8

同被引文献49

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部